Sybrecht GW - Search Results

1

Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial.

Ukena D, Boewer C, Oldenkott B, Rathgeb F, Wurst W, Zech K, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Cancer Chemother Pharmacol. 1995;36(2):160-4. doi: 10.1007/BF00689202. Cancer Chemother Pharmacol. 1995. PMID: 7767953 Clinical Trial.

2

A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC).

Ukena D, Berg M, Leutz M, Zell L, Schlimmer P, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Lung Cancer. 1998 Jan;19(1):31-6. doi: 10.1016/s0169-5002(97)00071-8. Lung Cancer. 1998. PMID: 9493138 Clinical Trial.

3

[Principles of theophylline therapy in obstructive respiratory diseases].

Ukena D, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Pneumologie. 1992 Feb;46(2):49-51. Pneumologie. 1992. PMID: 1549553 German. No abstract available.

4

[Theophylline: new information about a proven drug. The dual effect in therapy of bronchial asthma].

Ukena D, Keller A, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Med Klin (Munich). 1994 Dec 15;89(12):668-74. Med Klin (Munich). 1994. PMID: 7870002 Review. German. No abstract available.

5

[Effectiveness and hematotoxicity of paclitaxel monotherapy in patients with advanced non-small cell bronchial carcinoma (NSCLC)].

Leutz M, Schlimmer P, Zell L, Ukena D, Sybrecht G. Leutz M, et al. Pneumologie. 1997 Jan;51(1):62-5. Pneumologie. 1997. PMID: 9132749 Clinical Trial. German.

6

[Therapy of obstructive respiratory tract diseases. V: Mediator antagonists].

Ukena D, Schlimmer P, Vogt J, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Med Klin (Munich). 1990 Aug 15;85(8):499-503. Med Klin (Munich). 1990. PMID: 1700264 Review. German. No abstract available.

7

[Function of platelet activating factor in asthma].

Ukena D, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Dtsch Med Wochenschr. 1988 Oct 21;113(42):1651-6. doi: 10.1055/s-2008-1067867. Dtsch Med Wochenschr. 1988. PMID: 2846251 Review. German. No abstract available.

8

Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction.

Ukena D, Rentz K, Reiber C, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Respir Med. 1995 Jul;89(6):441-4. doi: 10.1016/0954-6111(95)90214-7. Respir Med. 1995. PMID: 7644776 Free article. Clinical Trial.

9

Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.

Ukena D, Schudt C, Sybrecht GW. Ukena D, et al. Among authors: sybrecht gw. Biochem Pharmacol. 1993 Feb 24;45(4):847-51. doi: 10.1016/0006-2952(93)90168-v. Biochem Pharmacol. 1993. PMID: 7680859

10

[Perspectives on modulation of chemoresistance of malignant diseases].

Allerödder HP, Ukena D, Sybrecht GW. Allerödder HP, et al. Among authors: sybrecht gw. Pneumologie. 1993 Sep;47(9):513-7. Pneumologie. 1993. PMID: 7901849 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters